But also protects patients against new infections for at least two months after treatment.

Data confirm the absence of side effects and benefits of easier treatment ScheduleThe results of two new large scale studies have shown that the combination of dihydroartemisinin and piperaquine against uncomplicated against uncomplicated malaria to Sun which is comparable with other artemisinin-based combination therapies , but also protects patients against new infections for at least two months after treatment. The DHA / PQP combination is very well tolerated without significant side effects.

Sigma – in Italy in 1957 in Italy in 1957 and achieved global sales of EUR 665 million in 2007.Sigma – tau SpA invests 16 percent of its annual turnover in R & D. Sigma-tau’s 400 R & D staff are currently running 43 R & D projects. A total of 14 NCEs and 12 known molecular entities in 30 different indications are in various stages of development.Sculptra is is currently investigating for treating nasolabial folds wrinkles. At the 2006 at the 2006 American Society for Dermatological Annual Meeting of in Palm Springs, CA. Indicated Sculptra , consistency and progressive and significant improvements over from baseline pleats evaluation scores 3 weeks and after last treatment and further through 13 months ago follow-up -. Follow-up the Sculptra is patients had folds estimate Partituren that were less than 2 on 13-month mail – treatment compared with four per cent of COSMOPLAST Themes.